Fewer than 800 Scots have received weight loss jabs on NHS, BBC finds

• Only 5 of 14 Scottish health boards currently offer weight loss medications (GLP-1 agonists) on the NHS, with fewer than 800 patients treated to date—indicating highly inconsistent access across regions
• This patchy provision suggests significant variation in local commissioning decisions and resource allocation for weight loss treatments in Scotland, creating potential equity issues for patients
• Clinicians should be aware of their local health board's policy on GLP-1 agonist prescribing for weight loss, as availability remains severely limited and inconsistent across Scottish NHS services

Only five of Scotland's 14 health boards currently offer the treatment specifically for weight loss, it has emerged.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.